Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Destiny Pharma to participate in panel discussion at the Cantor Antibiotics Summit

Destiny Pharma
Posted on: 11 Jan 18

Brighton, United Kingdom – 11 January 2018 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR), announces that Dr Bill Love, Chief Scientific Officer and Founder of Destiny Pharma, will participate in the panel discussion titled ‘Novel Ways to Treat and/or Address Infections’ at the Cantor Antibiotics Summit on Wednesday 17 January 2018 at 12:15pm EST at the Omni Berkshire Hotel, 21 East 52nd Street, New York, NY 10022.


The Cantor Antibiotics Summit, hosted by Cantor Fitzgerald, will bring together leading antibiotic companies to discuss novel ways to treat infections, what will drive the uptake of these new products, and important catalysts to look forward to in 2018.


For further information, please contact:


Destiny Pharma

Neil Clark, CEO

Simon Sacerdoti, CFO

+44 (0)1273 704 440


FTI Consulting

Simon Conway / Victoria Foster Mitchell / Hanna Skeppner

+44 (0) 20 3727 1000


Cantor Fitzgerald Europe (Nominated Adviser and Broker)

Philip Davies / Will Goode, Corporate Finance

+44 (0)20 7894 8337


About Destiny Pharma

Destiny Pharma is an established, clinical stage, innovative biotechnology company focused on the development of novel medicines that represent a new approach to the treatment of infectious disease. These potential new medicines are being developed to address the need for new drugs for the prevention and treatment of life-threatening infections caused by antibiotic-resistant bacteria, often referred to as “superbugs”. Tackling anti-microbial resistance has become a global imperative recognised by the WHO and the United Nations, as well as the G7 and the G20 countries. For further information, please visit

Editor's Details

Mike Wood

Last updated on: 11/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.